OPUS GENETICS INC(IRD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IRD OPUS GENETICS INC

Pre-Mkt 07-31 06:58:06 EDT

3.84

+0.37

+10.66%

盘前3.89

+0.05+1.30%

04:28 EDT

High3.88	Low3.42	Vol1.04M
Open3.46	D1 Closing3.47	Amplitude13.11%
Mkt Cap317.05M	Tradable Cap248.05M	Total Shares82.57M
T/O3.85M	T/O Rate1.61%	Tradable Shares64.60M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"IRD","market":"US","secType":"STK","nameCN":"OPUS GENETICS INC","latestPrice":3.84,"timestamp":1785441600000,"preClose":3.47,"halted":0,"volume":1037225,"hourTrading":{"tag":"盘前","latestPrice":3.89,"preClose":3.84,"latestTime":"04:28 EDT","volume":16,"amount":59.09,"timestamp":1785486505692,"change":0.05,"changeRate":0.013021,"amplitude":0.098958},"delay":0,"changeRate":0.10662824207492785,"floatShares":64596300,"shares":82565835,"eps":-1.3548,"marketStatus":"Pre-Mkt","change":0.37,"latestTime":"07-31 06:58:06 EDT","open":3.46,"high":3.875,"low":3.4201,"amount":3848359.49246,"amplitude":0.131095,"askPrice":4.22,"askSize":100,"bidPrice":3.85,"bidSize":507,"shortable":3,"etf":0,"ttmEps":-1.3548,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1785504600000},"marketStatusCode":1,"adr":0,"listingDate":1100235600000,"exchange":"NASDAQ","adjPreClose":3.84,"preHourTrading":{"tag":"盘前","latestPrice":3.89,"preClose":3.84,"latestTime":"04:28 EDT","volume":16,"amount":59.09,"timestamp":1785486505692,"change":0.05,"changeRate":0.013021,"amplitude":0.098958},"postHourTrading":{"tag":"盘后","latestPrice":3.84,"preClose":3.84,"latestTime":"19:40 EDT","volume":17927,"amount":69610.472,"timestamp":1785454808957,"change":0,"changeRate":0,"amplitude":0.041667},"volumeRatio":1.115688469456524,"impliedVol":1.4702,"impliedVolPercentile":0.556},"requestUrl":"/m/hq/s/IRD/tweets","defaultTab":"tweets","newsList":[{"id":"2655389160","title":"Analysts Offer Insights on Healthcare Companies: Quince Therapeutics (QNCX) and Opus Genetics (IRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2655389160","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655389160?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:50","pubTimestamp":1785444632,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Quince Therapeutics (QNCX) and Opus Genetics (IRD) w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quince-therapeutics-qncx-and-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quince-therapeutics-qncx-and-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","QNCX","LABU","BK4581","HCSG","IRD","XBI","LU0029874061.USD","BK4139","XLV","BK4137","BK4007","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655692867","title":"TD Cowen Initiates Opus Genetics at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2655692867","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655692867?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:45","pubTimestamp":1785325555,"startTime":"0","endTime":"0","summary":"Opus Genetics (IRD) has an average rating of buy and mean price target of $10.65, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSIB","BK7129","BK4585","BK4007","BK4127","COWN","IRD.AU","TD","IRD","BK4207","BK4566","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655637188","title":"Opus Genetics Inc : TD Cowen Initiates Coverage with Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2655637188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655637188?lang=en_us&edition=fundamental","pubTime":"2026-07-29 17:37","pubTimestamp":1785317827,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V122:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655786534","title":"Opus Genetics initiated with a Buy at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2655786534","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655786534?lang=en_us&edition=fundamental","pubTime":"2026-07-29 17:35","pubTimestamp":1785317719,"startTime":"0","endTime":"0","summary":"TD Cowen initiated coverage of Opus Genetics (IRD) with a Buy rating without a price target The company’s adeno-associated virus gene therapies rep...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opus-genetics-initiated-with-a-buy-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opus-genetics-initiated-with-a-buy-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","BK4007","BK4139","GSIB","BK4207","TD","COWN","BK4585","IRD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650187486","title":"Analysts Offer Insights on Healthcare Companies: Forte Biosciences (FBRX), Sarepta Therapeutics (SRPT) and Opus Genetics (IRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650187486","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650187486?lang=en_us&edition=fundamental","pubTime":"2026-07-10 19:50","pubTimestamp":1783684213,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Forte Biosciences (FBRX), Sarepta Therapeutics (SRPT...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-forte-biosciences-fbrx-sarepta-therapeutics-srpt-and-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-forte-biosciences-fbrx-sarepta-therapeutics-srpt-and-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0029874061.USD","HCSG","XLV","BK4581","SRPT","BK4139","BK4588","IE00BJT1NW94.SGD","LU0128526141.USD","BK4137","IE00BJJMRZ35.SGD","BK4585","IE0002141913.USD","BK4007","SRPU","IE0009355771.USD","XBI","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IRD","FBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650496922","title":"Opus Genetics sets September timeline for retinal disease trial data","url":"https://stock-news.laohu8.com/highlight/detail?id=2650496922","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650496922?lang=en_us&edition=fundamental","pubTime":"2026-07-09 21:10","pubTimestamp":1783602610,"startTime":"0","endTime":"0","summary":"Opus Genetics (IRD) provided updates on its ongoing OPGx-BEST1 Phase 1/2 clinical trial targeting BEST-1 associated inherited retinal diseases. The...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opus-genetics-sets-september-timeline-for-retinal-disease-trial-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opus-genetics-sets-september-timeline-for-retinal-disease-trial-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4558","BEST","GDOC","IRD","HYLG","BK4139","BK4007","IDNA","BK4131","BK4502","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650268259","title":"Opus Genetics - to Announce Opgx-best1 Three-month Topline Data from Cohort 1 in September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2650268259","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650268259?lang=en_us&edition=fundamental","pubTime":"2026-07-09 19:02","pubTimestamp":1783594944,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nFWN43B0KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649991616","title":"Analysts Are Bullish on Top Healthcare Stocks: Tenet Healthcare (THC), Opus Genetics (IRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649991616","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649991616?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:50","pubTimestamp":1783518612,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tenet Healthcare (THC) and Opus Genetics (IRD) with ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-tenet-healthcare-thc-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-tenet-healthcare-thc-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0130103400.USD","IRD","LU0648000940.SGD","BK4007","THC","BK4185","LU0963586101.USD","LU2324357040.USD","LU1201861165.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649719376","title":"Analysts Are Bullish on These Healthcare Stocks: CVRx (CVRX), Opus Genetics (IRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649719376","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649719376?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:40","pubTimestamp":1783370423,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CVRx (CVRX), Opus Genetics (IRD) and Lifecore Biomed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-cvrx-cvrx-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-cvrx-cvrx-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4082","BK4007","IRD","BK4139","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649367675","title":"Opus Genetics: FDA-Backed Phase 3 Path and Strong Early Efficacy Support Reiterated Buy on IRD with Unchanged $10 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2649367675","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649367675?lang=en_us&edition=fundamental","pubTime":"2026-07-07 01:15","pubTimestamp":1783358132,"startTime":"0","endTime":"0","summary":"Opus Genetics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Francois Brisebois from LifeSci Capital reitera...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/opus-genetics-fda-backed-phase-3-path-and-strong-early-efficacy-support-reiterated-buy-on-ird-with-unchanged-10-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/opus-genetics-fda-backed-phase-3-path-and-strong-early-efficacy-support-reiterated-buy-on-ird-with-unchanged-10-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649867345","title":"Opus Genetics Price Target Maintained with a $12.00/share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2649867345","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649867345?lang=en_us&edition=fundamental","pubTime":"2026-07-07 01:04","pubTimestamp":1783357440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IRD/analyst-ratings(END) Dow Jones NewswiresJuly 06, 2026 13:04 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649627345","title":"Opus Genetics FDA alignment further de-risks path to market, says Chardan","url":"https://stock-news.laohu8.com/highlight/detail?id=2649627345","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649627345?lang=en_us&edition=fundamental","pubTime":"2026-07-06 21:55","pubTimestamp":1783346120,"startTime":"0","endTime":"0","summary":"After Opus Genetics (IRD) announced that it has reached alignment with the FDA on the design of its registrational Phase 3 clinical trial evaluatin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opus-genetics-fda-alignment-further-de-risks-path-to-market-says-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opus-genetics-fda-alignment-further-de-risks-path-to-market-says-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRD","BK4585","MEDX","BK4588","BK4139","GDOC","LABU","IDNA","BK4007","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649625129","title":"Opus Genetics Posts Press Release on FDA Alignment for Opgx-lca5 Phase 3 Trial Design","url":"https://stock-news.laohu8.com/highlight/detail?id=2649625129","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649625129?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:02","pubTimestamp":1783335762,"startTime":"0","endTime":"0","summary":"Opus Genetics posts press release on FDA alignment for OPGx-LCA5 Phase 3 trial designposted FDA alignment on a Phase 3 registrational trial for OPGx-LCA5 in LCA5-associated inherited retinal disease.F","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL2FySdt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","LU2210150020.SGD","LU0314104364.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","LU2095319765.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","SG9999014013.SGD","IE00BN0W2T93.GBP","IRD","SG9999014039.USD","IE00BGHQF748.EUR","BK4139","NDAQ","BK4007","BK4112","SG9999014021.USD","BK4585","IE00B3QW5Z07.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649675625","title":"Opus Genetics Announces FDA Alignment on Phase 3 Registrational Trial Design for Opgx-lca5 in Lca5-associated Inherited Retinal Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2649675625","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649675625?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:00","pubTimestamp":1783335602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA1MRSGZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IRD","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649625984","title":"Opus Genetics - FDA Allows Bla Submission Based on 6-month Efficacy Data for Opgx-lca5","url":"https://stock-news.laohu8.com/highlight/detail?id=2649625984","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649625984?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:00","pubTimestamp":1783335602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA1MRSGZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IRD","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649256236","title":"Opus Genetics - to Initiate Phase 3 Dosing in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2649256236","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649256236?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:00","pubTimestamp":1783335602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA1MRSGZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646344365","title":"Opus Genetics Shares Rise on Addition to Russell Indexes","url":"https://stock-news.laohu8.com/highlight/detail?id=2646344365","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646344365?lang=en_us&edition=fundamental","pubTime":"2026-06-26 22:32","pubTimestamp":1782484320,"startTime":"0","endTime":"0","summary":"Opus Genetics shares advanced after the company said it will be added to the Russell 3000, Russell 2000 and Russell Microcap indexes.Shares were recently up 9.9% at $4.09 in morning trading Friday.The biopharmaceutical company said the changes, part of this month's reconstitution of the Russell indexes, will take effect at the open of U.S. markets on June 29.Write to Doc Louallen at Doc.Louallen@wsj.com Dow Jones NewswiresJune 26, 2026 10:32 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646350129","title":"Opus Genetics Added to the Russell 3000®, Russell 2000® and Russell Microcap® Indexes","url":"https://stock-news.laohu8.com/highlight/detail?id=2646350129","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646350129?lang=en_us&edition=fundamental","pubTime":"2026-06-26 21:15","pubTimestamp":1782479706,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nFWN42Y0HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","IRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646287033","title":"JonesTrading Sticks to Their Buy Rating for Opus Genetics (IRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646287033","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646287033?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:56","pubTimestamp":1782388577,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Debanjana Chatterjee reiterated a Buy rating on Opus Genetics today and set a price target of $10.00. Chatterjee covers the He...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jonestrading-sticks-to-their-buy-rating-for-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jonestrading-sticks-to-their-buy-rating-for-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645564833","title":"Opus Genetics Inc : RBC Initiates Coverage With Outperform Rating; Price Target $10","url":"https://stock-news.laohu8.com/highlight/detail?id=2645564833","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645564833?lang=en_us&edition=fundamental","pubTime":"2026-06-23 19:18","pubTimestamp":1782213537,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nFWN42V0UL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocuphire.com;ir.opusgtx.com","stockEarnings":[{"period":"1week","weight":0.3151},{"period":"1month","weight":-0.0657},{"period":"3month","weight":-0.2529},{"period":"6month","weight":0.6623},{"period":"1year","weight":2.5229},{"period":"ytd","weight":0.9104}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":-0.0068},{"period":"3month","weight":0.0292},{"period":"6month","weight":0.0719},{"period":"1year","weight":0.169},{"period":"ytd","weight":0.0876}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy. The company also develops APX2009 and APX2014 that are preclinical product candidates for retina indications. The company was formerly known as Ocuphire Pharma, Inc. Opus Genetics, Inc. was founded in 2018 and is headquartered in Farmington Hills, Michigan.","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.077612},{"month":2,"riseRate":0.5,"avgChangeRate":0.090887},{"month":3,"riseRate":0.363636,"avgChangeRate":0.009762},{"month":4,"riseRate":0.428571,"avgChangeRate":0.498458},{"month":5,"riseRate":0.590909,"avgChangeRate":4.154221},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.020512},{"month":7,"riseRate":0.363636,"avgChangeRate":0.002154},{"month":8,"riseRate":0.380952,"avgChangeRate":-0.018628},{"month":9,"riseRate":0.47619,"avgChangeRate":-0.005112},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.082285},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.065655},{"month":12,"riseRate":0.454545,"avgChangeRate":0.054326}],"exchange":"NASDAQ","name":"OPUS GENETICS INC","nameEN":"OPUS GENETICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"OPUS GENETICS INC(IRD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest OPUS GENETICS INC(IRD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"OPUS GENETICS INC,IRD,OPUS GENETICS INC股票,OPUS GENETICS INC股票老虎,OPUS GENETICS INC股票老虎国际,OPUS GENETICS INC行情,OPUS GENETICS INC股票行情,OPUS GENETICS INC股价,OPUS GENETICS INC股市,OPUS GENETICS INC股票价格,OPUS GENETICS INC股票交易,OPUS GENETICS INC股票购买,OPUS GENETICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"OPUS GENETICS INC(IRD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest OPUS GENETICS INC(IRD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction